{"id":71460,"date":"2025-09-18T10:27:10","date_gmt":"2025-09-18T10:27:10","guid":{"rendered":"https:\/\/kanboapp.com\/industries\/pharmaceutical\/transforming-risk-visibility-in-pharmaceutical-procurement-navigating-regulatory-challenges-and-financial-opportunities-for-associate-managers\/"},"modified":"2025-09-18T10:27:10","modified_gmt":"2025-09-18T10:27:10","slug":"transforming-risk-visibility-in-pharmaceutical-procurement-navigating-regulatory-challenges-and-financial-opportunities-for-associate-managers","status":"publish","type":"page","link":"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-risk-visibility-in-pharmaceutical-procurement-navigating-regulatory-challenges-and-financial-opportunities-for-associate-managers\/","title":{"rendered":"Transforming Risk Visibility in Pharmaceutical Procurement: Navigating Regulatory Challenges and Financial Opportunities for Associate Managers"},"content":{"rendered":"<style> @media(min-width:1728px) { .tytulek{font-size:34px!important;max-width: 1200px!important;} .sekcja-tekst { margin-left: 40px!important; margin-right: 40px!important;} .artykul{margin-bottom:120px!important; margin-top:120px!important;} .menu-lewe a:hover { background:#E9F4FE!important; font-weight:600!important; font-size:16px!important; cursor:pointer!important; } .menu-lewe a { background:#FAFAFA; padding:8px 8px; border-radius: 8px; display: inline-block; outline: none; color:#0C3658!important; font-weight:600!important; font-size:16px!important; line-height: 150% !important;} .menu-lewe{margin-bottom: 8px!important;} .kolumna-tekst{    flex-basis:35%!important;} .compact-nag{display:none!important; } .naglowek-duzy {margin-bottom:24px!important; margin-top: 48px!important; font-size:25px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.25px!important; line-height:1.2!important;} .naglowek-maly {margin-bottom:20px!important; font-size:19px!important; font-style:normal; font-weight:700!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .naglowek-start {margin-bottom:40px!important; margin-top: 0px!important; font-size:25px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.02em!important; line-height:1.2!important;}  .tekst-para {font-size:17px!important;line-height:160%!important;margin-bottom:24px!important;} .tekst-para-maly {font-size:14px!important;line-height:160%!important;margin-bottom:24px!important;} .prawy-tytul{font-size:16px!important;} .prawy-tekst {font-size:14px!important;} .prawy-link a{font-size:16px!important;} .spis { display:block!important; } .spis2 { display:block!important; } .pasek-lewy { margin-left:7%!important; } .pasek-prawy {  margin-right:7%!important; } } @media(min-width: 1440px) and (max-width:1727px) { .tytulek{font-size:34px!important;max-width: 1200px!important;} .sekcja-tekst { margin-left: 40px!important; margin-right: 40px!important;} .artykul{margin-bottom:120px!important; margin-top:120px!important;} .menu-lewe a:hover { background:#E9F4FE!important; font-weight:600!important; font-size:16px!important; cursor:pointer!important; } .menu-lewe a { background:#FAFAFA; padding:8px 8px; border-radius: 8px; display: inline-block; outline: none; color:#0C3658!important; font-weight:600!important; font-size:16px!important; line-height: 150% !important;} .menu-lewe{margin-bottom: 8px!important;} .kolumna-tekst{flex-basis:35%!important;} .compact-nag{display:none!important; } .naglowek-duzy {margin-bottom:24px!important; margin-top: 48px!important; font-size:25px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.25px!important; line-height:1.2!important;} .naglowek-maly {margin-bottom:20px!important; font-size:19px!important; font-style:normal; font-weight:700!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .naglowek-start {margin-bottom:40px!important; margin-top: 0px!important; font-size:25px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .tekst-para {font-size:17px!important;line-height:160%!important;margin-bottom:24px!important;} .tekst-para-maly {font-size:14px!important;line-height:160%!important;margin-bottom:24px!important;} .prawy-tytul{font-size:16px!important;} .prawy-tekst {font-size:14px!important;} .prawy-link a{font-size:16px!important;} .spis { display:block!important; } .spis2 { display:block!important; } .pasek-lewy {  margin-left:7%!important; } .pasek-prawy {  margin-right:7%!important; } } @media (min-width: 1024px) and (max-width:1439px) { .tytulek{font-size:34px!important;max-width: 1200px!important;} .sekcja-tekst { margin-left: 40px!important; margin-right: 40px!important;} .artykul{margin-bottom:120px!important; margin-top:120px!important;} .menu-lewe a:hover { background:#E9F4FE!important; font-weight:600!important; font-size:16px!important; cursor:pointer!important; } .menu-lewe a { background:#FAFAFA; padding:8px 8px; border-radius: 8px; display: inline-block; outline: none; color:#0C3658!important; font-weight:600!important; font-size:16px!important; line-height: 150% !important;} .menu-lewe{margin-bottom: 8px!important;} .kolumna-tekst{flex-basis:35%!important;} .compact-nag{display:none!important; } .naglowek-duzy {margin-bottom:24px!important; margin-top: 32px!important; font-size:25px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.25px!important; line-height:1.2!important;} .naglowek-maly {margin-bottom:20px!important; font-size:19px!important; font-style:normal; font-weight:700!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .naglowek-start {margin-bottom:40px!important; margin-top: 0px!important; font-size:25px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .tekst-para {font-size:17px!important;line-height:160%!important;margin-bottom:24px!important;} .tekst-para-maly {font-size:14px!important;line-height:160%!important;margin-bottom:24px!important;} .prawy-tytul{font-size:16px!important;} .prawy-tekst {font-size:14px!important;} .prawy-link a{font-size:16px!important;} .spis { display:block!important; } .spis2{ display:block!important; } .pasek-lewy {  margin-left:7%!important; } .pasek-prawy {  margin-right:7%!important; } } @media (min-width: 782px) and (max-width:1023px) { .tytulek{font-size:25px!important;max-width: 1200px!important;} .sekcja-tekst { margin-left: 40px!important; margin-right: 40px!important;}  .artykul{margin-bottom:80px!important; margin-top:30px!important;} .menu-lewe a:hover { background:#E9F4FE!important; font-weight:600!important; font-size:14px!important; cursor:pointer!important; } .menu-lewe a { background:#FAFAFA; padding:10px 4px; border-radius: 8px; display: inline-block; outline: none; color:#0C3658!important; font-weight:600!important; font-size:14px!important; line-height: 150% !important;}  .menu-lewe{margin-bottom: 8px!important;} .kolumna-tekst{flex-basis:60%!important;} .compact-nag{display:block!important; } .naglowek-duzy {margin-bottom:24px!important; margin-top: 32px!important; font-size:19px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.19px!important; line-height:1.2!important;} .naglowek-maly {margin-bottom:20px!important; font-size:16px!important; font-style:normal; font-weight:700!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .naglowek-start {margin-bottom:40px!important; margin-top: 32px!important; font-size:25px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .tekst-para {font-size:14px!important;line-height:160%!important;margin-bottom:24px!important;} .tekst-para-maly {font-size:12px!important;line-height:160%!important;margin-bottom:24px!important;} .prawy-tytul{font-size:16px!important;} .prawy-tekst {font-size:13px!important;} .prawy-link a{font-size:16px!important;} .spis { display:block!important; } .spis2 { display:none!important; } .pasek-lewy { margin-left:32px!important; } .pasek-prawy {margin-right:32px!important; } } @media (max-width:781px) {  .tytulek{font-size:25px!important;max-width: 1200px!important;} .sekcja-tekst { margin-left: 16px!important; margin-right: 16px!important;}  .artykul{margin-bottom:80px!important; margin-top:30px!important;} .menu-lewe a:hover { background:#E9F4FE!important; font-weight:600!important; font-size:14px!important; cursor:pointer!important; } .menu-lewe a { background:#FAFAFA; padding:10px 4px; border-radius: 8px; display: inline-block; outline: none; color:#0C3658!important; font-weight:600!important; font-size:14px!important; line-height: 150% !important;} .menu-lewe{margin-bottom: 8px!important;} .kolumna-tekst{flex-basis:100%!important;} .compact-nag{display:block!important; } .naglowek-duzy {margin-bottom:24px!important; margin-top: 48px!important; font-size:19px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.19px!important; line-height:1.2!important;} .naglowek-maly {margin-bottom:20px!important; font-size:16px!important; font-style:normal; font-weight:700!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .naglowek-start {margin-bottom:40px!important; margin-top: 32px!important; font-size:25px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .tekst-para {font-size:14px!important;line-height:160%!important;margin-bottom:24px!important;} .tekst-para-maly {font-size:12px!important;line-height:160%!important;margin-bottom:24px!important;} .prawy-tytul{font-size:16px!important;} .prawy-tekst {font-size:13px!important;} .prawy-link a{font-size:16px!important;} .spis { display:none!important; } .spis2 { display:none!important; } .pasek-lewy { margin-left:16px!important; } .pasek-prawy {margin-right:16px!important; } } .prawy-link a:hover { color:#145A92!important} .banner { margin-top:80px; margin-bottom:80px; } .jazda-nowsza { position:sticky!important; top: 120px; overflow: auto; max-height: 85vh; }  .fobrazek { margin-bottom: -40px!important; } .sekcja5-przycisk a:hover { background: linear-gradient(0deg, rgba(0, 0, 0, 0.15), rgba(0, 0, 0, 0.15)), #ED4B9E!important; }  .sekcja5-przycisk a:focus { background: linear-gradient(0deg, rgba(0, 0, 0, 0.15), rgba(0, 0, 0, 0.15)), #ED4B9E!important; } .vlp-layout-blogs .vlp-block-0 {font-weight: 600!important; } .prawy-tytul-pulpit {font-size:19px!important;} .ct-container-narrow {max-width: 1200px!important;}  :nth-last-child(1 of .tekst-para) {margin-bottom: 0px!important;} <\/style><script> function lewemenu(zm) { var elements = document.getElementsByClassName(\"menu-lewe\"); var i,link1,link2; for (i = 0; i < elements.length; i++) {    link1 = elements[i].getElementsByTagName(\"a\");     link1[0].style.fontWeight = \"600\";     link1[0].style.backgroundColor= \"#FAFAFA\"; } link2 = elements[zm].getElementsByTagName(\"a\"); link2[0].style.fontWeight = \"600\"; link2[0].style.backgroundColor= \"#E9F4FE\"; } <\/script><div class=\"wp-block-getwid-section alignfull alignfull getwid-margin-top-none getwid-margin-bottom-none getwid-section-content-full-width\"><div class=\"wp-block-getwid-section__wrapper getwid-padding-top-none getwid-padding-bottom-none getwid-padding-left-none getwid-padding-right-none getwid-margin-left-none getwid-margin-right-none\" style=\"min-height:100vh\"><div class=\"wp-block-getwid-section__inner-wrapper\"><div class=\"wp-block-getwid-section__background-holder\"><div class=\"wp-block-getwid-section__background has-background\" style=\"background-color:#fafafa\"><\/div><div class=\"wp-block-getwid-section__foreground\"><\/div><\/div><div class=\"wp-block-getwid-section__content\"><div class=\"wp-block-getwid-section__inner-content\"><div class=\"wp-block-columns alignfull artykul is-layout-flex wp-container-core-columns-is-layout-f96e3eba wp-block-columns-is-layout-flex\" style=\"margin-top:0px;margin-bottom:0px\"><div class=\"wp-block-column pasek-lewy spis jazda-nowsza is-layout-flow wp-block-column-is-layout-flow\"><div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-995f960e wp-block-columns-is-layout-flex\"><div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\"><p class=\"menu-lewe wp-elements-61e399e7fb18d3b988947bbfdf1af00a wp-block-paragraph\" onclick=\"lewemenu(0)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-risk-visibility-in-pharmaceutical-procurement-navigating-regulatory-challenges-and-financial-opportunities-for-associate-managers\/#section1\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-risk-visibility-in-pharmaceutical-procurement-navigating-regulatory-challenges-and-financial-opportunities-for-associate-managers\/#section1\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">Why change?<\/a><\/p><p class=\"menu-lewe wp-elements-2266a880a6999f1857c7ce44140df978 wp-block-paragraph\" onclick=\"lewemenu(1)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-risk-visibility-in-pharmaceutical-procurement-navigating-regulatory-challenges-and-financial-opportunities-for-associate-managers\/#section2\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-risk-visibility-in-pharmaceutical-procurement-navigating-regulatory-challenges-and-financial-opportunities-for-associate-managers\/#section2\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">Background \/ Definition<\/a><\/p><p class=\"menu-lewe wp-elements-741ec3008a4e654c47de8cc688c64d46 wp-block-paragraph\" onclick=\"lewemenu(2)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-risk-visibility-in-pharmaceutical-procurement-navigating-regulatory-challenges-and-financial-opportunities-for-associate-managers\/#section3\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-risk-visibility-in-pharmaceutical-procurement-navigating-regulatory-challenges-and-financial-opportunities-for-associate-managers\/#section3\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">Case-Style Mini-Examples<\/a><\/p><p class=\"menu-lewe wp-elements-bbfb08a486fb675d2d89a28924b83f75 wp-block-paragraph\" onclick=\"lewemenu(3)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-risk-visibility-in-pharmaceutical-procurement-navigating-regulatory-challenges-and-financial-opportunities-for-associate-managers\/#section4\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-risk-visibility-in-pharmaceutical-procurement-navigating-regulatory-challenges-and-financial-opportunities-for-associate-managers\/#section4\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">What will change?<\/a><\/p><p class=\"menu-lewe wp-elements-c9b17cb86a6d2383949f434a723067df wp-block-paragraph\" onclick=\"lewemenu(4)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-risk-visibility-in-pharmaceutical-procurement-navigating-regulatory-challenges-and-financial-opportunities-for-associate-managers\/#section5\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-risk-visibility-in-pharmaceutical-procurement-navigating-regulatory-challenges-and-financial-opportunities-for-associate-managers\/#section5\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">What will not change?<\/a><\/p><p class=\"menu-lewe wp-elements-5b050559270525582e383987b07abbbf wp-block-paragraph\" onclick=\"lewemenu(5)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-risk-visibility-in-pharmaceutical-procurement-navigating-regulatory-challenges-and-financial-opportunities-for-associate-managers\/#section6\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-risk-visibility-in-pharmaceutical-procurement-navigating-regulatory-challenges-and-financial-opportunities-for-associate-managers\/#section6\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">Key management questions (Q\/A)<\/a><\/p><p class=\"menu-lewe wp-elements-92a8c8ef0ea72d673d7a40a71bfa8ee0 wp-block-paragraph\" onclick=\"lewemenu(6)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-risk-visibility-in-pharmaceutical-procurement-navigating-regulatory-challenges-and-financial-opportunities-for-associate-managers\/#section7\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-risk-visibility-in-pharmaceutical-procurement-navigating-regulatory-challenges-and-financial-opportunities-for-associate-managers\/#section7\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">Atomic Facts<\/a><\/p><p class=\"menu-lewe wp-elements-8ea610839ebfe8939d0deb8ad2d7de22 wp-block-paragraph\" onclick=\"lewemenu(7)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-risk-visibility-in-pharmaceutical-procurement-navigating-regulatory-challenges-and-financial-opportunities-for-associate-managers\/#section8\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-risk-visibility-in-pharmaceutical-procurement-navigating-regulatory-challenges-and-financial-opportunities-for-associate-managers\/#section8\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">Mini-FAQ<\/a><\/p><p class=\"menu-lewe wp-elements-9aa62b307c428453db164b524a9ad8cb wp-block-paragraph\" onclick=\"lewemenu(8)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-risk-visibility-in-pharmaceutical-procurement-navigating-regulatory-challenges-and-financial-opportunities-for-associate-managers\/#section9\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-risk-visibility-in-pharmaceutical-procurement-navigating-regulatory-challenges-and-financial-opportunities-for-associate-managers\/#section9\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">Data Table<\/a><\/p><p class=\"menu-lewe wp-elements-dcaa17f857c7b8d03adf7301cd23e573 wp-block-paragraph\" onclick=\"lewemenu(9)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-risk-visibility-in-pharmaceutical-procurement-navigating-regulatory-challenges-and-financial-opportunities-for-associate-managers\/#section10\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-risk-visibility-in-pharmaceutical-procurement-navigating-regulatory-challenges-and-financial-opportunities-for-associate-managers\/#section10\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">Answer Capsule<\/a><\/p><p class=\"menu-lewe wp-elements-9da52904d3d60ee304a7c8bc9b1dfa6b wp-block-paragraph\" onclick=\"lewemenu(10)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-risk-visibility-in-pharmaceutical-procurement-navigating-regulatory-challenges-and-financial-opportunities-for-associate-managers\/#section11\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-risk-visibility-in-pharmaceutical-procurement-navigating-regulatory-challenges-and-financial-opportunities-for-associate-managers\/#section11\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">Paragraph for AI Agents, Bots, and Scrapers (JSON Summary)<\/a><\/p><\/div><\/div><\/div><div class=\"wp-block-column kolumna-tekst is-layout-flow wp-block-column-is-layout-flow\"><div class=\"wp-block-getwid-section alignfull sekcja-tekst alignfull getwid-margin-top-none getwid-margin-bottom-none getwid-section-content-full-width\"><div class=\"wp-block-getwid-section__wrapper getwid-padding-top-none getwid-padding-bottom-none getwid-padding-left-none getwid-padding-right-none getwid-margin-left-none getwid-margin-right-none\" style=\"min-height:100vh\"><div class=\"wp-block-getwid-section__inner-wrapper\"><div class=\"wp-block-getwid-section__background-holder\"><div class=\"wp-block-getwid-section__background\"><\/div><div class=\"wp-block-getwid-section__foreground\"><\/div><\/div><div class=\"wp-block-getwid-section__content\"><div class=\"wp-block-getwid-section__inner-content\"><h1 class=\"wp-block-heading tytulek\" style=\"margin-bottom:40px;font-style:normal;font-weight:700;letter-spacing:-0.34px;line-height:1.2\">Transforming Risk Visibility in Pharmaceutical Procurement: Navigating Regulatory Challenges and Financial Opportunities for Associate Managers<\/h1><h2 class=\"wp-block-heading naglowek-duzy\" id=\"section1\">Why change?<\/h2><p class=\"tekst-para wp-block-paragraph\">Risk visibility in the pharmaceutical industry is a critical aspect due to the complex and high-stakes nature of drug development and production. The pressures surrounding risk visibility can be categorized into several key areas:<\/p><p class=\"tekst-para wp-block-paragraph\">1. Regulatory Compliance: Pharmaceutical companies must adhere to stringent regulatory requirements and guidelines provided by agencies such as the FDA in the United States or the EMA in Europe. Effective risk visibility ensures compliance with these regulations, which are essential for market approval and continued operation. Non-compliance can lead to significant legal repercussions, financial penalties, and reputational damage.<\/p><p class=\"tekst-para wp-block-paragraph\">2. Operational Efficiency: Transparency in identifying and managing risks across the drug development and manufacturing lifecycle can enhance operational efficiency. With clear risk visibility, companies can anticipate potential challenges, allocate resources effectively, and streamline processes. Without this, inefficiencies can lead to costly delays and wastage.<\/p><p class=\"tekst-para wp-block-paragraph\">3. Patient Safety: The ultimate goal of pharmaceutical risk management is to ensure patient safety. Comprehensive risk visibility helps in identifying potential adverse effects of drugs, manufacturing defects, and supply chain vulnerabilities. Failure here could risk patient health, leading to product recalls, loss of trust from healthcare providers and patients, and potential litigation.<\/p><p class=\"tekst-para wp-block-paragraph\">4. Market Competition: The pharmaceutical industry is highly competitive, with companies racing to bring safe and effective drugs to market. Efficient risk management can provide a strategic advantage by accelerating product development timelines and ensuring quality, thus influencing market share.<\/p><p class=\"tekst-para wp-block-paragraph\">5. Financial Performance: Risks in pharmaceutical development are inherently tied to financial outcomes. Drug recalls, failed clinical trials, and compliance breaches all pose significant financial risks. Clear risk visibility enables proactive risk mitigation strategies, safeguarding against financial losses.<\/p><p class=\"tekst-para wp-block-paragraph\"> Quantifying the Risk of Inaction<\/p><p class=\"tekst-para wp-block-paragraph\">Quantifying the risks of inaction involves considering the potential cost and impact of not addressing the identified risks effectively:<\/p><p class=\"tekst-para wp-block-paragraph\">- Regulatory Fines and Legal Costs: Non-compliance with regulatory requirements can lead to fines, which can range from millions to billions of dollars depending on the severity and scope of the violation.<\/p><p class=\"tekst-para wp-block-paragraph\">  <\/p><p class=\"tekst-para wp-block-paragraph\">- Product Recalls and Inventory Loss: The cost associated with recalling a pharmaceutical product can be substantial. This includes direct costs of retrieval and disposal, as well as indirect costs such as lost sales and diminished brand reputation.<\/p><p class=\"tekst-para wp-block-paragraph\">- Delayed Product Launches: Delays due to poor risk management can prevent companies from capturing market share, translating into lost revenue in the highly competitive pharmaceutical landscape.<\/p><p class=\"tekst-para wp-block-paragraph\">- Market Capitalization: Poor risk visibility can adversely affect a company's stock price, as investors factor in risk exposure into their valuation decisions. <\/p><p class=\"tekst-para wp-block-paragraph\">- Litigation Costs: Ineffective risk management may lead to patient harm and subsequently lawsuits, which can be financially crippling and damaging to a company's reputation.<\/p><p class=\"tekst-para wp-block-paragraph\">In addressing these challenges, adopting a risk visibility tool or platform can be beneficial. For instance, KanBo is an example of a digital solution that provides organizations with a visual, collaborative platform for enhancing transparency and managing projects, which can be applied to risk visibility in pharmaceuticals. This type of tool can facilitate efficient communication, track risk management tasks, and align stakeholders, ultimately leading to better decision-making and risk mitigation strategies.<\/p><p class=\"tekst-para wp-block-paragraph\">While KanBo is an example, it is essential for pharmaceutical companies to evaluate and choose tools that best fit their specific needs, ensuring alignment with their risk management objectives and regulatory requirements.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section2\">Background \/ Definition<\/h3><p class=\"tekst-para wp-block-paragraph\">Risk visibility for an Associate Manager-Procurement in the pharmaceutical industry involves the capacity to identify, assess, and manage potential risks that may arise in the procurement process or disrupt the supply chain. This can include risks related to supplier reliability, quality control, compliance with regulatory standards, price fluctuations, and delivery timelines. Key aspects of risk visibility typically involve:<\/p><p class=\"tekst-para wp-block-paragraph\">1. Identification: Recognizing potential risks, such as supplier reliability or geopolitical instability, which could affect procurement activities.<\/p><p class=\"tekst-para wp-block-paragraph\">  <\/p><p class=\"tekst-para wp-block-paragraph\">2. Assessment: Evaluating the probability and impact of identified risks on the business operations.<\/p><p class=\"tekst-para wp-block-paragraph\">  <\/p><p class=\"tekst-para wp-block-paragraph\">3. Mitigation: Developing strategies to manage or reduce the impact of these risks.<\/p><p class=\"tekst-para wp-block-paragraph\">4. Monitoring: Continuously observing the risk landscape for any changes or new emerging threats.<\/p><p class=\"tekst-para wp-block-paragraph\">Key Terms Explained:<\/p><p class=\"tekst-para wp-block-paragraph\">- Card Blocker: In the context of project management tools like KanBo, a card blocker represents an issue or obstacle that halts progress on a specific task or project (\"card\"). These blockers can be local (specific to a task), global (affecting multiple tasks or projects), or on-demand (occurring sporadically). They are used to categorize and make explicit the reasons behind work standstills.<\/p><p class=\"tekst-para wp-block-paragraph\">- Date Conflict: This refers to scheduling issues where start or due dates overlap or are inconsistent across related tasks or projects, creating challenges in prioritization and execution.<\/p><p class=\"tekst-para wp-block-paragraph\">- Card Relation: Connections between tasks that apply dependencies, either breaking larger tasks into smaller, manageable ones (parent and child), or sequencing tasks (next and previous). This helps define the order of operations crucial in managing dependencies in procurement projects.<\/p><p class=\"tekst-para wp-block-paragraph\">- Notification: Alerts or updates that inform users about important changes or developments related to the tasks they are monitoring. This helps ensure timely communication and action on critical developments.<\/p><p class=\"tekst-para wp-block-paragraph\">KanBo Reframing Risk Visibility:<\/p><p class=\"tekst-para wp-block-paragraph\">KanBo enhances risk visibility for the Associate Manager-Procurement by effectively managing card blockers, mapped dependencies, and providing critical notifications:<\/p><p class=\"tekst-para wp-block-paragraph\">1. Visible Blockers: In KanBo, the use of card blockers allows procurement managers to clearly see and categorize why a task might be stalled. This could be due to supplier issues, regulatory delays, or resource shortages. Making blockers visible helps in prioritizing which risks or issues to address first and allocate resources to resolve them.<\/p><p class=\"tekst-para wp-block-paragraph\">2. Mapped Dependencies: With card relations, procurement managers can map out dependencies between various tasks. For instance, the relation between supplier selection and contract negotiation tasks can be visually represented. This helps to understand the flow of operations and the impact of delays or changes in one task on others, enabling better risk management.<\/p><p class=\"tekst-para wp-block-paragraph\">3. Notifications: Real-time notifications ensure that all stakeholders are immediately aware of significant changes, such as the resolution of a card blocker or a shift in deadlines due to a date conflict. This keeps everyone informed and enables swift action to mitigate potential risks, reducing the likelihood of overlooked issues that could escalate into bigger problems.<\/p><p class=\"tekst-para wp-block-paragraph\">Overall, KanBo's features facilitate better risk visibility, proactive management, and communication within pharmaceutical procurement, ultimately ensuring more efficient and resilient operations.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section3\">Case-Style Mini-Examples<\/h3><p class=\"tekst-para wp-block-paragraph\"> Case Example: Enhancing Risk Visibility in Pharmaceutical Procurement with KanBo<\/p><p class=\"tekst-para wp-block-paragraph\">Background:<\/p><p class=\"tekst-para wp-block-paragraph\">David, an Associate Manager-Procurement at a leading pharmaceutical company, faces multiple challenges with risk visibility. The pharmaceutical procurement process is laden with complexities such as ensuring supplier reliability, maintaining quality control, navigating regulatory compliance, and managing delivery timelines, all under constant threat of risks. These challenges are amplified by outdated methods of tracking and managing procurement tasks, leading to delays, inefficiencies, and risks that echo throughout the supply chain.<\/p><p class=\"tekst-para wp-block-paragraph\">Challenges with Traditional Methods:<\/p><p class=\"tekst-para wp-block-paragraph\">1. Lack of Centralized Risk Documentation:<\/p><p class=\"tekst-para wp-block-paragraph\">   - David uses spreadsheets and emails to track potential issues with supplier shipments. This fragmentation causes missed updates and delayed responses to emerging risks, leading to sporadic purchasing delays and financial overruns.<\/p><p class=\"tekst-para wp-block-paragraph\">2. Inadequate Communication:<\/p><p class=\"tekst-para wp-block-paragraph\">   - Without real-time collaboration tools, communication between departments and suppliers frequently falters, resulting in confusion and misalignment on procurement priorities and timelines.<\/p><p class=\"tekst-para wp-block-paragraph\">3. Risk of Overlapping Tasks:<\/p><p class=\"tekst-para wp-block-paragraph\">   - Due to poor scheduling visibility, David often encounters scheduling conflicts, such as overlapping procurement tasks that create bottlenecks and improper resource allocation.<\/p><p class=\"tekst-para wp-block-paragraph\">4. Delayed Reaction to Changes:<\/p><p class=\"tekst-para wp-block-paragraph\">   - Market fluctuations or supplier disruptions often go unnoticed until they significantly impact operations due to the lack of a real-time alert system to notify stakeholders promptly.<\/p><p class=\"tekst-para wp-block-paragraph\">Solution with KanBo:<\/p><p class=\"tekst-para wp-block-paragraph\">Implementing KanBo transformed David's procurement process across several dimensions:<\/p><p class=\"tekst-para wp-block-paragraph\">1. Comprehensive Risk Documentation and Visibility through Card Blockers:<\/p><p class=\"tekst-para wp-block-paragraph\">   - With KanBo's card blocker feature, David can now clearly indicate and categorize issues holding up a task. Each procurement card (task) can detail the nature of its blocker\u2014be it a local supplier issue, a global regulatory holdup, or a demand-specific delay. This transparency allows David to prioritize resolution activities effectively and involve the right stakeholders.<\/p><p class=\"tekst-para wp-block-paragraph\">2. Improved Communication with Card Relations:<\/p><p class=\"tekst-para wp-block-paragraph\">   - By creating card relations, David effectively maps the dependencies between tasks, such as those between supplier evaluation and contract negotiations. This visualization aids in understanding task sequences and ensures dependencies are clear, preventing the previously common issue of task realization out of order.<\/p><p class=\"tekst-para wp-block-paragraph\">3. Corrective Scheduling via Date Conflict Alerts:<\/p><p class=\"tekst-para wp-block-paragraph\">   - KanBo's date conflict feature equips David with alerts when task timelines overlap. This forewarning allows him to adjust schedules in advance, aligning procurement activities efficiently and minimizing resource wastage.<\/p><p class=\"tekst-para wp-block-paragraph\">4. Prompt Notifications for Real-Time Reaction:<\/p><p class=\"tekst-para wp-block-paragraph\">   - Real-time notifications ensure David and his team stay updated on crucial developments, such as the immediate resolution of a blocker or necessary adjustments to deliverable timelines. This agility limits the escalation of issues and maintains smooth supply chain operations.<\/p><p class=\"tekst-para wp-block-paragraph\">Outcome:<\/p><p class=\"tekst-para wp-block-paragraph\">Through the implementation of KanBo, David has significantly enhanced risk visibility within his procurement operations. Real-time insights and efficient task management mitigate potential risks, improve communication across teams, and optimize resource allocations. The pharmaceutical company benefits from improved supply chain resilience, quicker time-to-market response, and compliance adherence, reinforcing its competitive positioning and safeguarding its market share.<\/p><p class=\"tekst-para wp-block-paragraph\">In summary, KanBo adapts to the dynamic needs of pharmaceutical procurement, providing David and his team with a powerful toolset to proactively manage risks and ensure operational excellence.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section4\">What will change?<\/h3><p class=\"tekst-para wp-block-paragraph\">Executive Summary: Enhancing Risk Visibility in Pharmaceutical Procurement with KanBo<\/p><p class=\"tekst-para wp-block-paragraph\">In the pharmaceutical industry, effective procurement is crucial for ensuring timely and compliant drug production. Traditional tools often fall short in providing comprehensive risk visibility. KanBo, a collaborative work management platform, revolutionizes this process by enhancing risk visibility through structured organization, real-time updates, and efficient communication. Here's how KanBo transforms old-school methods:<\/p><p class=\"tekst-para wp-block-paragraph\">1. Core Concepts & Navigation:<\/p><p class=\"tekst-para wp-block-paragraph\">   - Traditional Tools: Rely on separate, often disconnected systems for task management and communication.<\/p><p class=\"tekst-para wp-block-paragraph\">   - KanBo Approach: Integrates all procurement tasks within a hierarchical structure of workspaces, spaces, and cards, ensuring interconnected visibility and streamlined navigation.<\/p><p class=\"tekst-para wp-block-paragraph\">2. User and Workspace Management:<\/p><p class=\"tekst-para wp-block-paragraph\">   - Old Methods: Manual updates and static access controls often lead to delays and miscommunication.<\/p><p class=\"tekst-para wp-block-paragraph\">   - KanBo Solution: Real-time user activity streams and flexible access levels ensure that the right people have the right information at the right time.<\/p><p class=\"tekst-para wp-block-paragraph\">3. Card Management and Risk Tracking:<\/p><p class=\"tekst-para wp-block-paragraph\">   - Old School: Static spreadsheets and emails make tracking blockers cumbersome.<\/p><p class=\"tekst-para wp-block-paragraph\">   - KanBo Innovation: Uses card blockers and relations to explicitly mark and track risks, dependencies, and task progress, allowing immediate identification and resolution of procurement issues.<\/p><p class=\"tekst-para wp-block-paragraph\">4. Document Management:<\/p><p class=\"tekst-para wp-block-paragraph\">   - Previous Systems: Separate document storage layers increase the risk of outdated information.<\/p><p class=\"tekst-para wp-block-paragraph\">   - KanBo Integration: Links documents directly to cards and spaces, ensuring that updates are propagated instantly, reducing compliance risks and enhancing audit readiness.<\/p><p class=\"tekst-para wp-block-paragraph\">5. Search, Filtering, and Reporting:<\/p><p class=\"tekst-para wp-block-paragraph\">   - Traditional Tools: Inefficient data retrieval and reporting processes.<\/p><p class=\"tekst-para wp-block-paragraph\">   - KanBo's Advantage: Comprehensive search, filtering, and forecasting tools provide real-time insights into procurement activities, making risk assessment data-driven and immediate.<\/p><p class=\"tekst-para wp-block-paragraph\">6. Visualization and Scenario Planning:<\/p><p class=\"tekst-para wp-block-paragraph\">   - Conventional Methods: Limited capabilities for visualizing project timelines and dependencies.<\/p><p class=\"tekst-para wp-block-paragraph\">   - With KanBo: Visual tools like Gantt and Mind Maps empower managers to foresee and plan for potential disruptions, improving strategic decision-making.<\/p><p class=\"tekst-para wp-block-paragraph\">KanBo's Modern Approach facilitates a proactive, efficient, and visible risk management process, replacing outdated methods with dynamic, integrated solutions. The platform enhances collaboration and operational resilience, crucial for pharmaceutical procurement's complex and compliance-driven environment.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section5\">What will not change?<\/h3><p class=\"tekst-para wp-block-paragraph\">When considering Risk Visibility for an Associate Manager-Procurement in the Pharmaceutical sector, it's essential to acknowledge elements that remain constant despite technological advancements. Leadership judgment, strategy ownership, and accountability continue to be inherently human attributes. While technology serves to amplify risk visibility, these core aspects of leadership remain unchanged. Moreover, a human-first approach underscores the importance of empathy, ethical considerations, and decision-making nuances that technology cannot replicate, ensuring balance and insight in risk management processes.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section6\">Key management questions (Q\/A)<\/h3><p class=\"tekst-para wp-block-paragraph\"> Risk Visibility for Associate Manager-Procurement in Pharmaceuticals:<\/p><p class=\"tekst-para wp-block-paragraph\">Who did what and when?  <\/p><p class=\"tekst-para wp-block-paragraph\">- Task responsibilities and timelines are tracked using tools like KanBo, where each task is assigned to individual team members with specific deadlines.<\/p><p class=\"tekst-para wp-block-paragraph\">What threatens the critical path?  <\/p><p class=\"tekst-para wp-block-paragraph\">- Supplier delays, regulatory compliance issues, and unforeseen market changes pose threats to the critical path in procurement processes.<\/p><p class=\"tekst-para wp-block-paragraph\">Where are bottlenecks?  <\/p><p class=\"tekst-para wp-block-paragraph\">- Bottlenecks commonly occur at supplier selection stages, quality control, and regulatory approvals due to delays or unforeseen dependencies.<\/p><p class=\"tekst-para wp-block-paragraph\">Which tasks are overdue and why?  <\/p><p class=\"tekst-para wp-block-paragraph\">- Tasks often become overdue due to unforeseen supplier issues, compliance checks taking longer than anticipated, or resource allocation problems. Tools like KanBo help to identify and categorize these blockers for timely resolution.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section7\">Atomic Facts<\/h3><p class=\"tekst-para wp-block-paragraph\">1. Regulatory Compliance: Non-compliance with pharmaceutical regulations can result in penalties reaching billions of dollars, which underscores the importance of maintaining risk visibility to adhere to guidelines from agencies like the FDA and EMA.<\/p><p class=\"tekst-para wp-block-paragraph\">2. Operational Efficiency: Clear risk visibility in procurement can prevent costly delays and inefficiencies, as it enables pharmaceutical companies to anticipate potential challenges in the drug development and manufacturing processes.<\/p><p class=\"tekst-para wp-block-paragraph\">3. Patient Safety: Effective risk visibility is crucial to identifying and mitigating risks associated with drug safety, including adverse effects and manufacturing defects, thereby protecting patient health and avoiding product recalls.<\/p><p class=\"tekst-para wp-block-paragraph\">4. Market Competition: Companies with strong risk management and visibility can accelerate product development, offering a competitive edge in a market where speed and quality significantly influence market share.<\/p><p class=\"tekst-para wp-block-paragraph\">5. Financial Performance: Ineffective risk management in pharmaceuticals can lead to financial losses from failed trials, recalls, and compliance breaches, emphasizing the need for proactive risk visibility strategies.<\/p><p class=\"tekst-para wp-block-paragraph\">6. Supplier Reliability: In procurement, identifying risks related to supplier reliability and geopolitical factors is essential to maintaining a stable supply chain and avoiding disruptions.<\/p><p class=\"tekst-para wp-block-paragraph\">7. Digital Tools for Risk Management: Solutions like KanBo offer platforms to enhance risk visibility and management by making blockers and dependencies explicit, thus facilitating more effective decision-making and communication.<\/p><p class=\"tekst-para wp-block-paragraph\">8. Notification Systems: Timely notifications about critical developments help procurement managers quickly address issues and mitigate risks, preventing minor problems from escalating.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section8\">Mini-FAQ<\/h3><p class=\"tekst-para wp-block-paragraph\">1. What is risk visibility in pharmaceutical procurement?<\/p><p class=\"tekst-para wp-block-paragraph\">Risk visibility in pharmaceutical procurement involves identifying, assessing, managing, and monitoring potential risks that could disrupt the supply chain or procurement processes. This includes risks related to supplier reliability, quality control, compliance with regulatory standards, price fluctuations, and delivery timelines.<\/p><p class=\"tekst-para wp-block-paragraph\">2. How does regulatory compliance affect risk visibility in procurement?<\/p><p class=\"tekst-para wp-block-paragraph\">Regulatory compliance is a major factor in risk visibility as it ensures that procurement processes meet stringent industry standards. Non-compliance can lead to legal repercussions and financial penalties, making it essential to have mechanisms in place for early risk identification and management to maintain adherence to regulations.<\/p><p class=\"tekst-para wp-block-paragraph\">3. What are the benefits of using a tool like KanBo for risk visibility?<\/p><p class=\"tekst-para wp-block-paragraph\">Using a tool like KanBo enhances risk visibility by making blockers visible, mapping task dependencies, and providing real-time notifications. It helps procurement managers prioritize issues, understand operational flows, and ensure timely communication, facilitating better risk management and decision-making.<\/p><p class=\"tekst-para wp-block-paragraph\">4. How can I identify potential risks in pharmaceutical procurement?<\/p><p class=\"tekst-para wp-block-paragraph\">Potential risks can be identified by examining supplier reliability, geopolitical instability, regulatory changes, quality control issues, and market dynamics. Continuous observation and assessment of these areas ensure timely identification of risks that could impact procurement activities.<\/p><p class=\"tekst-para wp-block-paragraph\">5. What are card blockers and how do they assist in managing procurement risks?<\/p><p class=\"tekst-para wp-block-paragraph\">Card blockers in project management tools like KanBo represent obstacles that halt progress on tasks. They categorize reasons behind work stoppages, such as supplier issues or resource shortages, helping procurement managers address and prioritize them effectively.<\/p><p class=\"tekst-para wp-block-paragraph\">6. Why is monitoring important in risk visibility?<\/p><p class=\"tekst-para wp-block-paragraph\">Continuous monitoring is crucial because it helps in observing any changes or new emerging threats in the risk landscape. It ensures that procurement strategies remain relevant and adaptive, preventing overlooked issues from escalating into bigger problems.<\/p><p class=\"tekst-para wp-block-paragraph\">7. What role do notifications play in risk management for procurement?<\/p><p class=\"tekst-para wp-block-paragraph\">Real-time notifications keep stakeholders informed about significant developments, like the resolution of a card blocker or deadline shifts. This prompt flow of information enables swift action to mitigate risks, reducing the likelihood of procurement disruptions.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section9\">Data Table<\/h3><p class=\"tekst-para wp-block-paragraph\">```<\/p><p class=\"tekst-para wp-block-paragraph\">Table: Risk Management and Visibility for Associate Manager-Procurement in Pharmaceuticals<\/p><p class=\"tekst-para wp-block-paragraph\">| Aspect                      | Key Considerations                                                   | Potential Risk Factors                        | Mitigation Strategies                                              |<\/p><p class=\"tekst-para wp-block-paragraph\">|-----------------------------|----------------------------------------------------------------------|-----------------------------------------------|---------------------------------------------------------------------|<\/p><p class=\"tekst-para wp-block-paragraph\">| Regulatory Compliance       | Adherence to FDA\/EMA standards                                        | Non-compliance, legal repercussions           | Regular audits, training programs, compliance checklists            |<\/p><p class=\"tekst-para wp-block-paragraph\">| Supplier Reliability        | Consistent supply and quality of materials                           | Supplier failure, geopolitical issues         | Diversified supplier base, robust contracts, alternative suppliers  |<\/p><p class=\"tekst-para wp-block-paragraph\">| Quality Control             | Assurance of material standards and production quality               | Defective materials compromising product quality | Pre-qualification processes, stringent quality checks               |<\/p><p class=\"tekst-para wp-block-paragraph\">| Price Fluctuations          | Financial forecasting and budgeting                                  | Market volatility, unexpected cost increases  | Long-term contracts, price locks, market analysis                   |<\/p><p class=\"tekst-para wp-block-paragraph\">| Delivery Timelines          | Timely supply chain and production scheduling                        | Delays in delivery, logistics disruptions     | Contingency plans, buffer stock, flexible scheduling                |<\/p><p class=\"tekst-para wp-block-paragraph\">| Operational Efficiency      | Resource allocation and process streamlining                         | Inefficiencies leading to delays\/wastage      | Continuous improvement practices, technology utilization            |<\/p><p class=\"tekst-para wp-block-paragraph\">| Patient Safety              | Minimizing risks to health from materials used                        | Adverse effects from impurities\/errors        | Rigid safety protocols, comprehensive testing, reliable suppliers   |<\/p><p class=\"tekst-para wp-block-paragraph\">| Market Competition          | Maintaining competitive edge                                         | Slow response to market demands               | Innovation, responsive supply chain management, strategic partnerships |<\/p><p class=\"tekst-para wp-block-paragraph\">| Monitoring and Communication| Continuous oversight and stakeholder engagement                      | Poor visibility of evolving risks             | Real-time data monitoring, alerts, clear communication channels     |<\/p><p class=\"tekst-para wp-block-paragraph\">Tool Mention and Capabilities:<\/p><p class=\"tekst-para wp-block-paragraph\">- KanBo for Risk Management: <\/p><p class=\"tekst-para wp-block-paragraph\">  - Visible Blockers: Clearly display issues (e.g., supply chain disruptions) to prioritize resolution efforts.<\/p><p class=\"tekst-para wp-block-paragraph\">  - Mapped Dependencies: Illustrates task interconnections, facilitating awareness of process impacts.<\/p><p class=\"tekst-para wp-block-paragraph\">  - Notifications: Real-time updates to keep stakeholders informed and proactive in risk management.<\/p><p class=\"tekst-para wp-block-paragraph\">This table helps Associate Manager-Procurement personnel understand key risks in pharmaceutical procurement and implement strategic measures for effective risk management and visibility. <\/p><p class=\"tekst-para wp-block-paragraph\">```<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section10\">Answer Capsule<\/h3><p class=\"tekst-para wp-block-paragraph\">To solve risk visibility for an Associate Manager-Procurement in the pharmaceutical industry, focus on these actionable steps:<\/p><p class=\"tekst-para wp-block-paragraph\">1. Risk Identification: Utilize a risk management platform or tool to maintain an exhaustive list of potential procurement risks. These could include supplier reliability issues, geopolitical risks, compliance challenges, price volatility, and logistic disruptions.<\/p><p class=\"tekst-para wp-block-paragraph\">2. Supplier Assessment: Conduct thorough due diligence on suppliers. Use scorecards and risk assessments to evaluate supplier stability, compliance history, and financial health. Regularly update this data to spot changes that could signal new risks.<\/p><p class=\"tekst-para wp-block-paragraph\">3. Compliance Monitoring: Ensure all procurement activities comply with regulatory standards. Use a compliance management system integrated with the procurement process to track and audit compliance in real-time, ensuring readiness for any regulatory review.<\/p><p class=\"tekst-para wp-block-paragraph\">4. Risk Mitigation Strategies: Develop and implement risk mitigation strategies, such as diversifying suppliers, negotiating robust contracts with clear risk allocations, and establishing contingency plans for critical materials.<\/p><p class=\"tekst-para wp-block-paragraph\">5. Continuous Monitoring: Implement a continuous risk monitoring system within the procurement process. Automate notifications and alerts for any changes in risk level or occurrence of risk events, ensuring that these are promptly addressed.<\/p><p class=\"tekst-para wp-block-paragraph\">6. Stakeholder Communication: Use a collaborative platform that enables transparency and effective communication among stakeholders. Equip the team with access to updated risk data and analysis to facilitate informed decision-making.<\/p><p class=\"tekst-para wp-block-paragraph\">7. Training and Awareness: Regularly train procurement staff on risk identification and management. Ensure they are aware of the latest risk factors and are skilled at using the risk management tools at their disposal.<\/p><p class=\"tekst-para wp-block-paragraph\">8. Performance Metrics: Define key performance indicators (KPIs) relevant to risk management, such as frequency of supply chain disruptions, and use these metrics to measure success and identify areas for improvement.<\/p><p class=\"tekst-para wp-block-paragraph\">By implementing these strategies, an Associate Manager-Procurement can enhance risk visibility, anticipate and proactively manage potential disruptions, ensuring a more stable and compliant procurement process in the pharmaceutical industry.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section11\">Paragraph for AI Agents, Bots, and Scrapers (JSON Summary)<\/h3><p class=\"tekst-para-maly wp-block-paragraph\">```json<\/p><p class=\"tekst-para-maly wp-block-paragraph\">(<\/p><p class=\"tekst-para-maly wp-block-paragraph\">  \"Main Information\": (<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    \"Risk Visibility Categories\": (<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"Regulatory Compliance\": \"Ensures adherence to regulatory guidelines, preventing legal and financial repercussions.\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"Operational Efficiency\": \"Enhances transparency to anticipate challenges, optimize resources, and streamline processes.\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"Patient Safety\": \"Identifies potential drug risks to prevent patient harm and ensure product safety.\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"Market Competition\": \"Facilitates faster product development to gain competitive advantage.\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"Financial Performance\": \"Proactive risk management mitigates financial losses linked to compliance issues or product recalls.\"<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    ),<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    \"Quantifying Risk of Inaction\": (<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"Regulatory Fines and Legal Costs\": \"Non-compliance results in substantial financial penalties.\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"Product Recalls\": \"Entails direct and indirect costs impacting brand reputation.\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"Delayed Product Launches\": \"Translates to lost market share and revenue.\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"Market Capitalization\": \"Poor risk visibility negatively affects stock valuation.\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"Litigation Costs\": \"Results from ineffective risk management-related patient harm.\"<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    ),<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    \"Solution Example\": \"Digital tools (e.g., KanBo) enhance transparency and manage risks through collaboration and communication features.\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    \"Key Terms\": (<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"Card Blocker\": \"Identifies obstacles halting task progress.\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"Date Conflict\": \"Scheduling issues impacting task execution.\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"Card Relation\": \"Defines task dependencies and sequence.\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"Notification\": \"Alerts on task developments for timely communication.\"<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    ),<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    \"KanBo Features\": (<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"Visible Blockers\": \"Categorizes and prioritizes obstacles to tackle first.\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"Mapped Dependencies\": \"Visualizes task relations to manage operations flow.\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"Notifications\": \"Real-time updates for proactive risk management.\"<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    )<\/p><p class=\"tekst-para-maly wp-block-paragraph\">  ),<\/p><p class=\"tekst-para-maly wp-block-paragraph\">  \"Specific Role Example\": \"Associate Manager-Procurement handles procurement risks like supplier reliability, quality control, and delivery timelines through identification, assessment, mitigation, and monitoring.\"<\/p><p class=\"tekst-para-maly wp-block-paragraph\">)<\/p><p class=\"tekst-para-maly wp-block-paragraph\">```<\/p><h3 class=\"wp-block-heading naglowek-start compact-nag\">Additional Resources<\/h3><h3 class=\"wp-block-heading has-text-align-left prawy-tytul compact-nag\" style=\"margin-top:0px;margin-bottom:8px;font-style:normal;font-weight:600;line-height:1.2\">Work Coordination Platform&nbsp;<\/h3><p class=\"has-text-align-left prawy-tekst compact-nag wp-block-paragraph\" style=\"margin-bottom:8px\">The KanBo Platform boosts efficiency and optimizes work management. Whether you need remote, onsite, or hybrid work capabilities, KanBo offers flexible installation options that give you control over your work environment.<\/p><p class=\"prawy-link compact-nag has-text-color has-link-color wp-elements-f81cac751942179cffc5595ea3093d69 wp-block-paragraph\" style=\"color:#1672bb;margin-bottom:24px;padding-top:8px;padding-bottom:8px;font-style:normal;font-weight:700;line-height:1.5\"><a href=\"https:\/\/kanboapp.com\/en\/\" target=\"_blank\" rel=\"noreferrer noopener\">KanBo Homepage \u2192<\/a><\/p><h3 class=\"wp-block-heading has-text-align-left prawy-tytul compact-nag\" style=\"margin-top:0px;margin-bottom:8px;font-style:normal;font-weight:600;line-height:1.2\">Getting Started with KanBo<\/h3><p class=\"has-text-align-left prawy-tekst compact-nag wp-block-paragraph\" style=\"margin-bottom:8px\">Explore KanBo Learn, your go-to destination for tutorials and educational guides, offering expert insights and step-by-step instructions to optimize.<\/p><p class=\"prawy-link compact-nag has-text-color has-link-color wp-elements-80007a93c5109043d5274205e4d68368 wp-block-paragraph\" style=\"color:#1672bb;margin-bottom:24px;padding-top:8px;padding-bottom:8px;font-style:normal;font-weight:700;line-height:1.5\"><a href=\"https:\/\/learn.kanboapp.com\/\" target=\"_blank\" rel=\"noreferrer noopener\">KanBo Learn Platform \u2192<\/a><\/p><h3 class=\"wp-block-heading has-text-align-left prawy-tytul compact-nag\" style=\"margin-top:0px;margin-bottom:8px;font-style:normal;font-weight:600;line-height:1.2\">DevOps Help<\/h3><p class=\"has-text-align-left prawy-tekst compact-nag wp-block-paragraph\" style=\"margin-bottom:8px\">Explore Kanbo's DevOps guide to discover essential strategies for optimizing collaboration, automating processes, and improving team efficiency.<\/p><p class=\"prawy-link compact-nag has-text-color has-link-color wp-elements-23fbce8bb46a861d3991ae1a29f1d971 wp-block-paragraph\" style=\"color:#1672bb;margin-bottom:0px;padding-top:8px;padding-bottom:8px;font-style:normal;font-weight:700;line-height:1.5\"><a href=\"https:\/\/help.kanboapp.com\/en\/devops\/\" target=\"_blank\" rel=\"noreferrer noopener\">KanBo Dev Portal \u2192<\/a><\/p><\/div><\/div><\/div><\/div><\/div><\/div><div class=\"wp-block-column pasek-prawy spis2 jazda-nowsza is-layout-flow wp-block-column-is-layout-flow\"><div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-995f960e wp-block-columns-is-layout-flex\"><div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"padding-right:16px;padding-left:16px\"><h3 class=\"wp-block-heading has-text-align-left prawy-tytul-pulpit\" style=\"margin-top:0px;margin-bottom:8px;font-style:normal;font-weight:600;line-height:1.2\">Work Coordination Platform&nbsp;<\/h3><p class=\"has-text-align-left prawy-tekst wp-block-paragraph\" style=\"margin-bottom:8px\">The KanBo Platform boosts efficiency and optimizes work management. Whether you need remote, onsite, or hybrid work capabilities, KanBo offers flexible installation options that give you control over your work environment.<\/p><p class=\"prawy-link has-text-color has-link-color wp-elements-40115c86dc2fe150fd9b1ed5dc10196e wp-block-paragraph\" style=\"color:#1672bb;margin-bottom:32px;padding-top:8px;padding-bottom:8px;font-style:normal;font-weight:700;line-height:1.5\"><a href=\"https:\/\/kanboapp.com\/en\/\" target=\"_blank\" rel=\"noreferrer noopener\">KanBo Homepage \u2192<\/a><\/p><h3 class=\"wp-block-heading has-text-align-left prawy-tytul-pulpit\" style=\"margin-top:0px;margin-bottom:8px;font-style:normal;font-weight:600;line-height:1.2\">Getting Started with KanBo<\/h3><p class=\"has-text-align-left prawy-tekst wp-block-paragraph\" style=\"margin-bottom:8px\">Explore KanBo Learn, your go-to destination for tutorials and educational guides, offering expert insights and step-by-step instructions to optimize.<\/p><p class=\"prawy-link has-text-color has-link-color wp-elements-02abac7c05b8b530fd3b1b7827aca587 wp-block-paragraph\" style=\"color:#1672bb;margin-bottom:32px;padding-top:8px;padding-bottom:8px;font-style:normal;font-weight:700;line-height:1.5\"><a href=\"https:\/\/learn.kanboapp.com\/\" target=\"_blank\" rel=\"noreferrer noopener\">KanBo Learn Platform \u2192<\/a><\/p><h3 class=\"wp-block-heading has-text-align-left prawy-tytul-pulpit\" style=\"margin-top:0px;margin-bottom:8px;font-style:normal;font-weight:600;line-height:1.2\">DevOps Help<\/h3><p class=\"has-text-align-left prawy-tekst wp-block-paragraph\" style=\"margin-bottom:8px\">Explore Kanbo's DevOps guide to discover essential strategies for optimizing collaboration, automating processes, and improving team efficiency.<\/p><p class=\"prawy-link has-text-color has-link-color wp-elements-09306734556c91c46ae8064a30b664b3 wp-block-paragraph\" style=\"color:#1672bb;margin-bottom:32px;padding-top:8px;padding-bottom:8px;font-style:normal;font-weight:700;line-height:1.5\"><a href=\"https:\/\/help.kanboapp.com\/en\/devops\/\" target=\"_blank\" rel=\"noreferrer noopener\">KanBo Dev Portal \u2192<\/a><\/p><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"","protected":false},"author":2,"featured_media":0,"parent":3013,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-71460","page","type-page","status-publish","hentry"],"blocksy_meta":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\r\n<title>Transforming Risk Visibility in Pharmaceutical Procurement: Navigating Regulatory Challenges and Financial Opportunities for Associate Managers - KanBo<\/title>\r\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\r\n<link rel=\"canonical\" href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-risk-visibility-in-pharmaceutical-procurement-navigating-regulatory-challenges-and-financial-opportunities-for-associate-managers\/\" \/>\r\n<meta property=\"og:locale\" content=\"en_US\" \/>\r\n<meta property=\"og:type\" content=\"article\" \/>\r\n<meta property=\"og:title\" content=\"Transforming Risk Visibility in Pharmaceutical Procurement: Navigating Regulatory Challenges and Financial Opportunities for Associate Managers - KanBo\" \/>\r\n<meta property=\"og:url\" content=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-risk-visibility-in-pharmaceutical-procurement-navigating-regulatory-challenges-and-financial-opportunities-for-associate-managers\/\" \/>\r\n<meta property=\"og:site_name\" content=\"KanBo\" \/>\r\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\r\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"18 minutes\" \/>\r\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/industries\\\/pharmaceutical\\\/transforming-risk-visibility-in-pharmaceutical-procurement-navigating-regulatory-challenges-and-financial-opportunities-for-associate-managers\\\/\",\"url\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/industries\\\/pharmaceutical\\\/transforming-risk-visibility-in-pharmaceutical-procurement-navigating-regulatory-challenges-and-financial-opportunities-for-associate-managers\\\/\",\"name\":\"Transforming Risk Visibility in Pharmaceutical Procurement: Navigating Regulatory Challenges and Financial Opportunities for Associate Managers - KanBo\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/#website\"},\"datePublished\":\"2025-09-18T10:27:10+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/industries\\\/pharmaceutical\\\/transforming-risk-visibility-in-pharmaceutical-procurement-navigating-regulatory-challenges-and-financial-opportunities-for-associate-managers\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/kanboapp.com\\\/en\\\/industries\\\/pharmaceutical\\\/transforming-risk-visibility-in-pharmaceutical-procurement-navigating-regulatory-challenges-and-financial-opportunities-for-associate-managers\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/industries\\\/pharmaceutical\\\/transforming-risk-visibility-in-pharmaceutical-procurement-navigating-regulatory-challenges-and-financial-opportunities-for-associate-managers\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Industries\",\"item\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/industries\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"KanBo for Pharmaceutical\",\"item\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/industries\\\/pharmaceutical\\\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Transforming Risk Visibility in Pharmaceutical Procurement: Navigating Regulatory Challenges and Financial Opportunities for Associate Managers\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/\",\"name\":\"KanBo\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/#organization\",\"name\":\"KanBo\",\"url\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/kanboapp.com\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/image-122.png\",\"contentUrl\":\"https:\\\/\\\/kanboapp.com\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/image-122.png\",\"width\":196,\"height\":52,\"caption\":\"KanBo\"},\"image\":{\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\r\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Transforming Risk Visibility in Pharmaceutical Procurement: Navigating Regulatory Challenges and Financial Opportunities for Associate Managers - KanBo","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-risk-visibility-in-pharmaceutical-procurement-navigating-regulatory-challenges-and-financial-opportunities-for-associate-managers\/","og_locale":"en_US","og_type":"article","og_title":"Transforming Risk Visibility in Pharmaceutical Procurement: Navigating Regulatory Challenges and Financial Opportunities for Associate Managers - KanBo","og_url":"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-risk-visibility-in-pharmaceutical-procurement-navigating-regulatory-challenges-and-financial-opportunities-for-associate-managers\/","og_site_name":"KanBo","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"18 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-risk-visibility-in-pharmaceutical-procurement-navigating-regulatory-challenges-and-financial-opportunities-for-associate-managers\/","url":"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-risk-visibility-in-pharmaceutical-procurement-navigating-regulatory-challenges-and-financial-opportunities-for-associate-managers\/","name":"Transforming Risk Visibility in Pharmaceutical Procurement: Navigating Regulatory Challenges and Financial Opportunities for Associate Managers - KanBo","isPartOf":{"@id":"https:\/\/kanboapp.com\/en\/#website"},"datePublished":"2025-09-18T10:27:10+00:00","breadcrumb":{"@id":"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-risk-visibility-in-pharmaceutical-procurement-navigating-regulatory-challenges-and-financial-opportunities-for-associate-managers\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-risk-visibility-in-pharmaceutical-procurement-navigating-regulatory-challenges-and-financial-opportunities-for-associate-managers\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-risk-visibility-in-pharmaceutical-procurement-navigating-regulatory-challenges-and-financial-opportunities-for-associate-managers\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/kanboapp.com\/en\/"},{"@type":"ListItem","position":2,"name":"Industries","item":"https:\/\/kanboapp.com\/en\/industries\/"},{"@type":"ListItem","position":3,"name":"KanBo for Pharmaceutical","item":"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/"},{"@type":"ListItem","position":4,"name":"Transforming Risk Visibility in Pharmaceutical Procurement: Navigating Regulatory Challenges and Financial Opportunities for Associate Managers"}]},{"@type":"WebSite","@id":"https:\/\/kanboapp.com\/en\/#website","url":"https:\/\/kanboapp.com\/en\/","name":"KanBo","description":"","publisher":{"@id":"https:\/\/kanboapp.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/kanboapp.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/kanboapp.com\/en\/#organization","name":"KanBo","url":"https:\/\/kanboapp.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/kanboapp.com\/en\/#\/schema\/logo\/image\/","url":"https:\/\/kanboapp.com\/wp-content\/uploads\/2023\/04\/image-122.png","contentUrl":"https:\/\/kanboapp.com\/wp-content\/uploads\/2023\/04\/image-122.png","width":196,"height":52,"caption":"KanBo"},"image":{"@id":"https:\/\/kanboapp.com\/en\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/kanboapp.com\/en\/wp-json\/wp\/v2\/pages\/71460","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/kanboapp.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/kanboapp.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/kanboapp.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/kanboapp.com\/en\/wp-json\/wp\/v2\/comments?post=71460"}],"version-history":[{"count":0,"href":"https:\/\/kanboapp.com\/en\/wp-json\/wp\/v2\/pages\/71460\/revisions"}],"up":[{"embeddable":true,"href":"https:\/\/kanboapp.com\/en\/wp-json\/wp\/v2\/pages\/3013"}],"wp:attachment":[{"href":"https:\/\/kanboapp.com\/en\/wp-json\/wp\/v2\/media?parent=71460"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}